EXAS - Company ID 0001124140
The table below shows EXACT SCIENCES CORP's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $3.25B | $2.76B | $2.50B | $2.08B | $1.77B | $1.49B |
| Cost of revenue | $984.24M | $840.15M | $737.56M | $661.36M | $458.76M | $354.32M |
| Gross profit | $2.26B | $1.92B | $1.76B | $1.42B | - | - |
| R&D | $523.00M | $431.21M | $426.93M | $394.19M | $385.65M | $554.05M |
EXACT SCIENCES CORP reported annual revenue of $3.25B for fiscal year 2025. That is up 17.7% from $2.76B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $99.38M (FY 2016) to $3.25B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $888.67M |
| $781.83M |
| $800.29M |
| $663.38M |
| $801.26M |
| $481.39M |
| Operating income | -$206.30M | -$1.05B | -$215.01M | -$593.51M | -$855.68M | -$767.70M |
| Income tax | $4.06M | -$7.30M | $2.40M | -$9.06M | -$246.88M | -$5.46M |
| Net income | -$207.95M | -$1.03B | -$204.15M | -$623.51M | -$595.63M | -$823.61M |
| EPS (diluted) | -$1.10 | -$5.59 | -$1.13 | -$3.54 | -$3.48 | -$5.45 |